Cephalexin 250 mg Dispersible TabletsCepolex 250 DT

TabletsPacking : 10 x 10 Alu

Composition- Cephalexin 250 mg Dispersible Tablets

MRP : 936.56/-

Prescribed By : General Physician, Dermatologist, Orthopaedic Surgeon, Paediatrician

Product Description

Key Benefits of Cepolex 250 DT

Strong gram-positive cover, particularly against staphylococci and streptococci
Well tolerated oral cephalosporin with a long record in community practice
Dispersible presentation supports paediatric and geriatric dosing
Manufactured at a WHO-GMP certified facility under GLP and ISO norms
Every batch quality tested in-house before dispatch

Indications of Cepolex 250 DT

Skin and soft tissue infections
Respiratory tract infections
ENT infections
Urinary tract infections
Bone and joint infections

How Cepolex 250 DT works

Cephalexin is a first-generation cephalosporin. It binds to penicillin-binding proteins and interrupts the final cross-linking step of bacterial cell wall construction, leaving the wall unable to hold the cell together. Activity is strongest against gram-positive organisms, particularly staphylococci and streptococci.

Why ChooseCepolex 250 DT?

Manufactured at a WHO-GMP certified facility under GLP, ISO and GMP norms, with raw material from approved vendors and in-house quality testing on every batch. Offered to PCD franchise partners on district-wise monopoly rights, with pan-India supply and complete promotional support.

Frequently asked questions about Cepolex 250 DT

Is monopoly available for this product?

Yes. District-wise monopoly rights are offered across India. Tell us your district and we will confirm availability.

What is the composition of Cepolex 250 DT?

Cephalexin 250 mg Dispersible Tablets.

Is this manufactured at a WHO-GMP certified facility?

Yes. Manufacturing follows GLP, WHO, ISO and GMP norms, and every batch is quality tested in-house before dispatch.

What is the minimum order quantity?

Please contact our team for the current MOQ and price structure for your territory.

Last updated on 29 August 2026

This information is for reference only and is not a substitute for advice from a qualified doctor or pharmacist. Please consult your physician before use.